Icosavax Inc (ICVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ICVX | BBOT | NVCT | ||
| Company | Icosavax Inc | Bridgebio Oncology Therapeutics Inc | Nuvectis Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 15.40 | 9.55 | 22.98 | ||
| High | 15.44 | 9.78 | 23.27 | ||
| Low | 15.28 | 9.34 | 22.36 | ||
| Last | 15.31 | 9.28 | 22.78 | ||
| Change | -0.14 | -0.32 | -0.55 | ||
| Percent Change | -0.91% | -3.33% | -2.36% | ||
| Volume | 9,315,200 | 36,263 | 14,636 | ||
| 20-Day Average Volume | 1,485,225 | 255,105 | 202,669 | ||
| Previous | 15.45 | 9.60 | 23.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.31 | 8.93 | 20.24 | ||
| 20-Day Raw Stochastic | 33.33% | 91.86% | 89.40% | ||
| 20-Day Relative Strength | 61.26 | 59.26 | 62.88 | ||
| Weighted Alpha | +7.30 | +3.59 | +93.80 | ||
| Today's Opinion | 96% Buy | 8% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.33% since 02/09/24 | +3.79% since 08/13/26 | +20.23% since 08/13/26 | ||
| Low | 15.20 on 02/15/24 | 8.80 on 08/14/26 | 18.51 on 08/17/26 | ||
| High | 15.58 on 02/14/24 | 9.72 on 08/19/26 | 23.74 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | -1.92% since 01/16/24 | +13.78% since 07/20/26 | +28.23% since 07/20/26 | ||
| Low | 15.17 on 01/23/24 | 8.00 on 08/03/26 | 17.89 on 08/04/26 | ||
| High | 15.78 on 01/18/24 | 9.72 on 08/19/26 | 23.74 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +64.45% since 11/16/23 | +8.74% since 05/20/26 | +117.50% since 05/20/26 | ||
| Low | 9.38 on 11/17/23 | 7.00 on 06/11/26 | 9.22 on 06/03/26 | ||
| High | 16.10 on 12/13/23 | 9.72 on 08/19/26 | 29.27 on 06/29/26 | ||
| 6-Month | |||||
| %Chg | +110.01% since 08/16/23 | -4.01% since 02/20/26 | +173.29% since 02/20/26 | ||
| Low | 5.88 on 10/27/23 | 7.00 on 06/11/26 | 7.17 on 03/30/26 | ||
| High | 16.10 on 12/13/23 | 11.02 on 03/06/26 | 29.27 on 06/29/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 766,878 | 769,671 | 760,138 | ||
| Shares Outstanding, K | 50,090 | 80,174 | 32,582 | ||
| Annual Sales, $M | 580,000 | 0 | 0 | ||
| Annual Net Income, $M | -91,760,000 | -134,040,000 | -26,440,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 0 | ||
| Last Qtr Income, $M | -22,040,000 | -56,450,000 | -7,020,000 | ||
| 60-Month Beta | 1.28 | 0.36 | -0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 11/14/23 | -0.62 on 08/11/26 | -0.30 on 08/04/26 | ||
| Latest Earnings Date | 04/04/24 | 11/11/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||